Atlas Venture Associates IX, L.P., 10% Owner at Intellia Therapeutics, Inc. (NTLA), sold 42,264 shares at $14.06 ($588K) on 2017-03-10, disclosed to the SEC on 2017-03-13.
Open-market sale of $588k NTLA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.85 | 15,628 | $216K | 36.8% |
| 2 | $13.85 | 15,628 | $216K | 36.8% |
| 3 | $14.06 | 5,504 | $77K | 13.2% |
| 4 | $14.06 | 5,504 | $77K | 13.2% |
| Total | $13.90 avg | 42,264 | $588K | 100% |